Ohio board rejects medical marijuana for autism
Cleveland.com highlights UC expert's testimony to State Medical Board
The State Medical Board of Ohio rejected proposals to add autism and female orgasmic difficulty disorder to the list of qualified conditions for which patients can obtain medical marijuana.
The decision came following testimony from experts including the University of Cincinnati's Craig Erickson, MD, associate professor in UC's College of Medicine and a Cincinnati Children's Hospital physician researcher, who spoke against the inclusion of autism on the approved conditions list.
Cleveland.com highlighted Erickson's and other experts' testimony in an article about the board's decision. Erickson told the board adults and children with autism are increasingly testing positive for THC even though there are not reports of clearly positive change in autism spectrum disorder patients.
Erickson added he's concerned that some patients are not capable of giving consent for cannabis, due to the communication deficits that are part of their autism spectrum disorder.
Read the Cleveland.com article.
Featured photo at top of marijuana leaves. Photo/Jeff W/Unsplash.
Related Stories
Finding purpose in the hardest moments
April 28, 2026
After nearly leaving nursing during the COVID-19 pandemic, Matt Depenbrock found renewed purpose in neonatal intensive care, leading him to develop Project HEALS—an innovative initiative aimed at improving NICU nurses’ confidence and competence in end-of-life care.
UC Clermont to launch redesigned neuroinclusive business degrees
April 28, 2026
Local 12’s “Good Morning Cincinnati” reported on UC Clermont College’s launch of redesigned business degree programs built with a neuroinclusive approach aimed at better supporting neurodivergent students.
CCM welcomes new piano faculty member Liza Stepanova
April 28, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of Liza Stepanova, DMA, as CCM's new Associate Professor of Piano. Her faculty appointment officially begins on Aug. 15, 2026. Praised by The New York Times for her "thoughtful musicality" and "fleet-fingered panache," Stepanova is in demand as a soloist, collaborator and educator.